Advertisements
Advertisement

BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG

BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG.....»»

Category:finance~latestSource:  asianageAug 4th, 2021


BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG

BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG.....»»

Category: finance~latestSource:  asianageRelated NewsAug 4th, 2021

40 pharma companies interested in producing anti COVID-19 drug, DRDO tells Madras High Court

40 pharma companies interested in producing anti COVID-19 drug, DRDO tells Madras High Court.....»»

Category: sports~latestSource:  googlenewsRelated NewsJun 25th, 2021

BDR Pharma ties up Eli Lilly for COVID-19 drug

BDR Pharma ties up Eli Lilly for COVID-19 drug.....»»

Category: news~orissaSource:  zeenewsRelated NewsMay 19th, 2021

BDR Pharma ties up Eli Lilly for COVID-19 drug

BDR Pharma ties up Eli Lilly for COVID-19 drug.....»»

Category: news~orissaSource:  zeenewsRelated NewsMay 19th, 2021

Natco Pharma signs pact with Eli Lilly for Baricitinib

Natco Pharma signs pact with Eli Lilly for Baricitinib.....»»

Category: news~andhra-pradeshSource:  siasatRelated NewsMay 18th, 2021

Torrent Pharma in a license agreement with Eli Lilly for baricitinib to treat Covid-19; Stock gains 1%

Torrent Pharma in a license agreement with Eli Lilly for baricitinib to treat Covid-19; Stock gains 1%.....»»

Category: finance~stockSource:  indiainfolineRelated NewsMay 14th, 2021

MSN Labs inks pact with Eli Lilly to make, market COVID drug Baricitinib

MSN Labs inks pact with Eli Lilly to make, market COVID drug Baricitinib.....»»

Category: sports~latestSource:  rediffRelated NewsMay 13th, 2021

Glenmark inks pact with SaNOtize to produce, market anti-COVID-19 nasal spray in India, other countries

Glenmark inks pact with SaNOtize to produce, market anti-COVID-19 nasal spray in India, other countries.....»»

Category: movies~sandalwoodSource:  sifyRelated NewsAug 2nd, 2021

Covid: After Covaxin, ZyCov-D jabs, Belagavi hospital to conduct trials of Sanofi vaccine

Covid: After Covaxin, ZyCov-D jabs, Belagavi hospital to conduct trials of Sanofi vaccine.....»»

Category: news~karnatakaSource:  newindianexpressRelated NewsJul 15th, 2021

Laurus Labs gets DRDO licence to make anti-COVID drug 2DG

Laurus Labs gets DRDO licence to make anti-COVID drug 2DG.....»»

Category: news~bangaloreSource:  thehinduRelated NewsJul 2nd, 2021

Dr Reddy"s Laboratories announces commercial launch of Covid-19 drug 2-DG

Dr Reddy"s Laboratories announces commercial launch of Covid-19 drug 2-DG.....»»

Category: finance~latestSource:  businessstandardRelated NewsJun 28th, 2021

Nepal inks $150-mn loan pact with World Bank for post-Covid growth

Nepal inks $150-mn loan pact with World Bank for post-Covid growth.....»»

Category: finance~latestSource:  businessstandardRelated NewsJun 27th, 2021

Why was DRDO’s COVID-19 drug licence given to only one laboratory, asks Madras HC

Why was DRDO’s COVID-19 drug licence given to only one laboratory, asks Madras HC.....»»

Category: movies~sandalwoodSource:  sifyRelated NewsJun 24th, 2021

DRDO’s anti-Covid drug priced at Rs 990 per sachet

DRDO’s anti-Covid drug priced at Rs 990 per sachet.....»»

Category: news~opedSource:  indianexpressRelated NewsMay 28th, 2021

DRDO’s 1st batch of anti-Covid drug 2DG launched

DRDO’s 1st batch of anti-Covid drug 2DG launched.....»»

Category: finance~latestSource:  theindianexpressRelated NewsMay 17th, 2021

Rajnath Singh to Distribute DRDO’s 2-DG Anti-COVID Drug Today

Rajnath Singh to Distribute DRDO’s 2-DG Anti-COVID Drug Today.....»»

Category: news~Source:  thequintRelated NewsMay 17th, 2021

UPL in license agreement with Japan"s Meiji Seika Pharma to excess of Flupyrimin for rice in Southeast Asia

UPL in license agreement with Japan"s Meiji Seika Pharma to excess of Flupyrimin for rice in Southeast Asia.....»»

Category: finance~stockSource:  indiainfolineRelated NewsMay 11th, 2021

Lupin enters into a license agreement with Eli Lilly for manufacturing Baricitinib in India to treat Covid

Lupin enters into a license agreement with Eli Lilly for manufacturing Baricitinib in India to treat Covid.....»»

Category: finance~stockSource:  indiainfolineRelated NewsMay 10th, 2021

Immediately license all patents necessary for vaccine, drug production: Jairam Ramesh

Immediately license all patents necessary for vaccine, drug production: Jairam Ramesh.....»»

Category: news~lucknowSource:  indianexpressRelated NewsMay 6th, 2021

MSD ties up with 5 Indian pharma majors for supply of oral COVID-19 drug Molnupiravir

MSD ties up with 5 Indian pharma majors for supply of oral COVID-19 drug Molnupiravir.....»»

Category: finance~latestSource:  rediffRelated NewsApr 27th, 2021